Cargando…

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy

BACKGROUND: Deficiency in butyrylcholinesterase (BChE), a condition commonly noticed in liver damage, inflammation, and malnutrition, has previously been associated with impaired prognosis in different malignancies. The aim of the present study was to investigate the value of pretreatment serum BChE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poetsch, Nina, Sturdza, Alina, Aust, Stefanie, Polterauer, Stephan, Grimm, Christoph, Schwameis, Richard, Pötter, Richard, Koelbl, Heinz, Reinthaller, Alexander, Seebacher, Veronika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488555/ https://www.ncbi.nlm.nih.gov/pubmed/30737542 http://dx.doi.org/10.1007/s00066-019-01430-z

Ejemplares similares

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery
por: Bekos, Christine, et al.
Publicado: (2019)

Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy
por: Sturdza, Alina, et al.
Publicado: (2017)

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data
por: Oberndorfer, Felicitas, et al.
Publicado: (2021)

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
por: Seebacher, Veronika, et al.
Publicado: (2017)

Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature
por: Mailath-Pokorny, Mariella, et al.
Publicado: (2016)

The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate
por: Bekos, Christine, et al.
Publicado: (2022)

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study
por: Seebacher, Veronika, et al.
Publicado: (2018)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

Prognostic value of serum creatine level in patients with vulvar cancer
por: Schwameis, Richard, et al.
Publicado: (2019)

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2015)

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
por: Bekos, Christine, et al.
Publicado: (2021)

Nomogram prediction for overall survival of patients diagnosed with cervical cancer
por: Polterauer, S, et al.
Publicado: (2012)

Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen
por: Seebacher, Veronika, et al.
Publicado: (2017)

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2020)

Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial
por: Seebacher, V, et al.
Publicado: (2013)

The impact of lymph node density on survival of cervical cancer patients
por: Polterauer, S, et al.
Publicado: (2010)

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
por: Paspalj, V., et al.
Publicado: (2021)

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older
por: Reiser, Elisabeth, et al.
Publicado: (2020)

The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study
por: Seebacher, Veronika, et al.
Publicado: (2009)

Influence of training level on cervical cone size and resection margin status at conization: a retrospective study
por: Montanari, Eliana, et al.
Publicado: (2018)

Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
por: Bekos, Christine, et al.
Publicado: (2018)

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
por: Grech, Christina T., et al.
Publicado: (2022)

Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer
por: Pötter, Richard, et al.
Publicado: (2011)

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2015)

The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2013)

Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report
por: Magdalena, Postl, et al.
Publicado: (2023)

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2010)

Reply: Lymph node density as a surrogate marker for positive lymph nodes
por: Polterauer, S, et al.
Publicado: (2011)

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

The prognostic value of four interleukin-1 gene polymorphisms in caucasian women with breast cancer – a multicenter study
por: Grimm, Christoph, et al.
Publicado: (2009)

Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters
por: Reiser, Elisabeth, et al.
Publicado: (2022)

Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer
por: Grimm, C, et al.
Publicado: (2013)

Adaptive image guided brachytherapy for cervical cancer: A combined MRI-/CT-planning technique with MRI only at first fraction
por: Nesvacil, Nicole, et al.
Publicado: (2013)

Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2012)

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial
por: Grimm, Christoph, et al.
Publicado: (2014)

Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study
por: Bekos, Christine, et al.
Publicado: (2017)

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients
por: Bartl, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tpn3peqh1iqvofc38p9is7m0p9